For the quarter ended June 2024, 10x Genomics (TXG) reported revenue of $153.1 million, up 4.3% over the same period last year. EPS came in at -$0.32, compared to -$0.53 in the year-ago quarter. The reported revenue represents a surprise of +1.46% over the Zacks Consensus Estimate of $150.9 million. With the consensus EPS estimate being -$0.47, the EPS surprise was +31.91%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine ...